Pyxis Oncology (PYXS) Current Leases (2020 - 2026)

Pyxis Oncology (PYXS) has reported Current Leases for 6 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Leases rose 16.33% year-over-year to $1.8 million in Q2 2026; TTM through Jun 2026 was $1.8 million, a 16.33% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 16.69% from the prior year.
• Current Leases was $1.8 million for Q2 2026 at Pyxis Oncology, up from $1.7 million in the prior quarter.
• Over five years, Current Leases peaked at $1.8 million in Q2 2026 and troughed at $527000.0 in Q2 2023.
• A 4-year average of $1.4 million and a median of $1.4 million in 2024 frame the typical range for Current Leases.
• Across the five-year window, Current Leases declined 15.91% in 2024 and soared 47.84% in 2025, its largest moves.
• Over 4 years, Current Leases stood at $1.2 million in 2023, then climbed by 17.69% to $1.4 million in 2024, then grew by 16.69% to $1.7 million in 2025, then gained by 7.8% to $1.8 million in 2026.
• The last three Current Leases figures came in at $1.8 million (Q2 2026), $1.7 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.